MARKET

SLP

SLP

Simulations Plus Inc
NASDAQ
18.40
+0.02
+0.11%
After Hours: 18.40 0 0.00% 16:15 08/21 EDT
OPEN
18.41
PREV CLOSE
18.38
HIGH
18.41
LOW
18.37
VOLUME
116.56K
TURNOVER
--
52 WEEK HIGH
21.01
52 WEEK LOW
11.09
MARKET CAP
372.14M
P/E (TTM)
45.98
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SLP last week (0810-0814)?
Weekly Report · 4d ago
Simulations Plus Advances Toward Altaris Acquisition With HSR Clearance
TipRanks · 08/13 21:41
Simulations Plus Clears HSR Waiting Period For Altaris Acquisition, Closing Expected In H2 2026
Benzinga · 08/13 21:02
Press Release: Simulations Plus Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Altaris
Dow Jones · 08/13 21:00
Weekly Report: what happened at SLP last week (0803-0807)?
Weekly Report · 08/10 09:42
Weekly Report: what happened at SLP last week (0727-0731)?
Weekly Report · 08/03 09:41
Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP
Barchart · 07/30 11:05
Simulation Plus, Inc. (NASDAQ: SLP) Investors Should Contact Robbins LLP for Information About Investigation
Barchart · 07/27 19:06
More
About SLP
Simulations Plus, Inc. specializes in model-informed and artificial intelligence (AI)-accelerated drug development. The Company helps its clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through science-based software and consulting solutions. The Company’s segments include Software and Services. The Company's Software segment supports pharmaceutical research, development, and commercialization through simulation, modeling, and AI-driven prediction. Its main products include GastroPlus, ADMET Predictor, MonolixSuite, and others for disease modeling and training, as well as Pro-ficiency for clinical operations. Its Services segment includes advanced consulting services across the entire drug development lifecycle. Its scientists and engineers specialize in drug discovery, pharmacokinetics, pharmacodynamics, drug modeling, clinical trial data analysis, regulatory strategy, and medical communications.

Webull offers Simulations Plus Inc stock information, including NASDAQ: SLP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SLP stock methods without spending real money on the virtual paper trading platform.